1 Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
2 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
3 Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
4 Seattle Biomedical Research Institute, Seattle, Washington, USA.
5 Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
6 Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
7 Duke Human Vaccine Institute, Durham, North Carolina, USA.
8 College of Life Science and Technology, Jinan University, Guangzhou, China.
9 Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
10 Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
11 Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
12 Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
13 Sanaria Inc., Rockville, Maryland, USA.
14 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. mpancera@fredhutch.org.
15 Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rseder@mail.nih.gov.
In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. Full details can be found in the correction notice.